Vés al contingut

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate to severe chronic peripheral neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Obert
  • Codi protocol: M602011079
  • Codi EudraCT: No aplica
  • Grup de recerca: Farmacologia Clínica
  • Servei: Anestèsia
  • Investigador/a principal:  Medel Rebollo, Francisco Javier
  • Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Fase: Fase II